Brief: Immutep Enters Clinical Trial Collaboration And Supply Agreement With Merck & Co
03/06/2024 02:21
June 3 (Reuters) - Immutep Ltd IMM.AX :
* ENTERED INTO A CLINICAL TRIAL COLLABORATION AND SUPPLY
AGREEMENT
WITH MERCK & CO., INC
* DEAL TO EVALUATE EFTILAGIMOD ALFA IN COMBINATION WITH
KEYTRUDA®
& CHEMOTHERAPY FOR TREATMENT OF METASTATIC NON-SMALL CELL LUNG
CANCER
Further company coverage: IMM.AX
((Reuters.Briefs@thomsonreuters.com;))